{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:46:24Z","timestamp":1782776784110,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801736"],"award-info":[{"award-number":["81801736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The synergistic suppressive effects of the radioimmunotherapy-induced abscopal effect on distant non-irradiated tumors have recently emerged as a research hotspot. However, studies on its specific regulatory role in adjacent sentinel lymph nodes (SLNs) remain limited. The deep location and small size of SLNs hinder the monitoring of treatment-related changes, underscoring the need for lymphography-based approaches. In this study, we aimed to evaluate the abscopal-like effect of radioimmunotherapy on SLNs in an H22 hepatocellular carcinoma mouse model via dynamic lymphography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      H22 murine hepatocarcinoma cells were transplanted into the right hind foot sole of C57BL\/6 mice. Fourteen days post-inoculation, mice with SLNs were selected and divided into six groups: control, isotype control Ig, anti-PD-1 alone, irradiation (IR) alone, irradiation\u2009+\u2009isotype control Ig, and IR\u2009+\u2009anti-PD-1. The volume and weights of tumors and non-irradiated SLNs were measured. The SLNs were imaged with \u00b9\u2078F-fluorodeoxyglucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG) dynamic lymphography at 14, 21, and 28 days post-inoculation. CD8 immunohistochemistry assays were performed to assess CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this mouse model, the IR\u2009+\u2009anti-PD-1 combination treatment exerted a marked suppressive effect on the growth of both irradiated tumors and non-irradiated SLNs, demonstrating a robust enhancement of the abscopal-like effect compared with the monotherapy groups. Mechanistic investigations demonstrated elevated CD8\u207a T cell infiltration in non-irradiated SLNs, suggesting that enhanced systemic anti-tumor immunity mediated the effect. Dynamic \u00b9\u2078F-FDG PET lymphography enabled clear visualization of SLNs as early as 30\u00a0s post-injection, with sustained imaging clarity for over 30\u00a0min. This method also demonstrated decreased radioactive accumulation in irradiated tumors and non-irradiated SLNs, confirming an enhanced abscopal-like effect with the IR and anti-PD-1 combination approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our data demonstrate that the regression of SLNs adjacent to the irradiation field, mediated by the abscopal-like effect of radioimmunotherapy, can be sensitively and effectively tracked via dynamic\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG lymphography. Furthermore, our findings provide an effective and straightforward lymphographic approach with substantial translational potential for assessing the efficacy of the radioimmunotherapeutic abscopal-like effect against SLNs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16140-w","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:04:41Z","timestamp":1778108681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the abscopal-like effect of radioimmunotherapy on sentinel lymph nodes in H22 hepatocellular carcinoma via dynamic lymphography"],"prefix":"10.1186","volume":"26","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"13","key":"16140_CR1","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/cncr.33483","volume":"127","author":"KK Broman","year":"2021","unstructured":"Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, et al. Active surveillance of patients who have sentinel node positive melanoma: an international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Cancer. 2021;127(13):2251\u201361.","journal-title":"Cancer"},{"issue":"8","key":"16140_CR2","doi-asserted-by":"publisher","first-page":"e004417","DOI":"10.1136\/jitc-2021-004417","volume":"10","author":"Z Eroglu","year":"2022","unstructured":"Eroglu Z, Broman KK, Thompson JF, Nijhuis A, Hieken TJ, Kottschade L, et al. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. J Immunother Cancer. 2022;10(8):e004417.","journal-title":"J Immunother Cancer"},{"issue":"22","key":"16140_CR3","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu X, Wang Z, Chen X, Wang L, Lu Y, et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell. 2022;185(22):4049\u201366.","journal-title":"Cell"},{"issue":"1","key":"16140_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12876-025-04030-7","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen J, Yu F, Zhang W, Zhong Y. Neoadjuvant chemotherapy with or without PD-1\/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials. BMC Gastroenterol. 2025;25(1):416.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"16140_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","volume":"20","author":"M McLaughlin","year":"2020","unstructured":"McLaughlin M, Patin EC, Pedersen M, Wilkins A, Dillon MT, Melcher AA, et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020;20(4):203\u201317.","journal-title":"Nat Rev Cancer"},{"key":"16140_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.ircmb.2023.03.010","volume":"378","author":"K Passelli","year":"2023","unstructured":"Passelli K, Rep\u00e1raz D, Herrera FG. Opportunities and challenges of low-dose radiation to enable immunotherapy efficacy. Int Rev Cell Mol Biol. 2023;378:137\u201356.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"30","key":"16140_CR7","doi-asserted-by":"publisher","first-page":"e01819","DOI":"10.1002\/advs.202501819","volume":"12","author":"L Lyu","year":"2025","unstructured":"Lyu L, Yi M, Chen J, Zhang J, Ma X, Zhang X, et al. Bispecific antibody targeting VEGF\/TGF-\u03b2 synergizes with local radiotherapy: turning tumors from cold to inflamed and amplifying abscopal effects. Adv Sci (Weinh). 2025;12(30):e01819.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"16140_CR8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.7150\/thno.118974","volume":"16","author":"H Li","year":"2026","unstructured":"Li H, Huang X, Yang J, Bai L, Shen M, Zhao Y, et al. Limitation-circumventing and strength-capitalizing hydrogel potentiates durable antitumor immunity and robust abscopal effect in radiotherapy. Theranostics. 2026;16(3):1432\u201344.","journal-title":"Theranostics"},{"issue":"6","key":"16140_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","volume":"57","author":"C Zhao","year":"2024","unstructured":"Zhao C, Wang C, Shan W, Wang Z, Chen X, Deng H. Nanomedicines for an enhanced immunogenic cell death-based in situ cancer vaccination response. Acc Chem Res. 2024;57(6):905\u201318.","journal-title":"Acc Chem Res"},{"key":"16140_CR10","doi-asserted-by":"publisher","first-page":"104325","DOI":"10.1016\/j.critrevonc.2024.104325","volume":"196","author":"B Yu","year":"2024","unstructured":"Yu B, Gao Y, Li J, Gao F, Zhang J, Li L, et al. Killing two birds with one stone: abscopal effect mechanism and its application prospect in radiotherapy. Crit Rev Oncol Hematol. 2024;196:104325.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"16140_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2967\/jnumed.117.196303","volume":"59","author":"H Lockau","year":"2018","unstructured":"Lockau H, Neuschmelting V, Ogirala A, Vilaseca A, Grimm J. Dynamic 18F-FDG PET lymphography for in vivo identification of lymph node metastases in murine melanoma. J Nucl Med. 2018;59(2):210\u201315.","journal-title":"J Nucl Med"},{"issue":"23","key":"16140_CR12","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","volume":"25","author":"R Luo","year":"2019","unstructured":"Luo R, Firat E, Gaedicke S, Guffart E, Watanabe T, Niedermann G. Cisplatin facilitates radiation-induced abscopal effects in conjunction with PD-1 checkpoint blockade through CXCR3\/CXCL10-Mediated T-cell Recruitment. Clin Cancer Res. 2019;25(23):7243\u201355.","journal-title":"Clin Cancer Res"},{"key":"16140_CR13","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.neo.2024.101099","volume":"60","author":"L Ma","year":"2025","unstructured":"Ma L, Li Y, Sakamoto Y, Xie L, Suzuki S, Yoshida Y, et al. Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody. Neoplasia. 2025;60:101099.","journal-title":"Neoplasia"},{"issue":"3","key":"16140_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.it.2022.01.006","volume":"43","author":"FG Herrera","year":"2022","unstructured":"Herrera FG, Romero P, Coukos G. Lighting up the tumor fire with low-dose irradiation. Trends Immunol. 2022;43(3):173\u201379.","journal-title":"Trends Immunol"},{"issue":"1","key":"16140_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3350\/cmh.2020.0095","volume":"27","author":"GS Yoo","year":"2021","unstructured":"Yoo GS, Ahn WG, Kim SY, Kang W, Choi C, Park HC. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: a murine model study. Clin Mol Hepatol. 2021;27(1):144\u201356.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"16140_CR16","first-page":"e85776","volume":"17","author":"I Barjij","year":"2025","unstructured":"Barjij I, Meliani M. Immunogenic cell death as a target for combination therapies in solid tumors: a systematic review toward a new paradigm in immuno-oncology. Cureus. 2025;17(6):e85776.","journal-title":"Cureus"},{"issue":"2","key":"16140_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/ijms22020535","volume":"22","author":"H Fukushima","year":"2021","unstructured":"Fukushima H, Yoshida S, Kijima T, Nakamura Y, Fukuda S, Uehara S, et al. Combination of cisplatin and irradiation induces immunogenic cell death and potentiates postirradiation anti-PD-1 treatment efficacy in urothelial carcinoma. Int J Mol Sci. 2021;22(2):535.","journal-title":"Int J Mol Sci"},{"key":"16140_CR18","doi-asserted-by":"publisher","first-page":"175883592513875","DOI":"10.1177\/17588359251387534","volume":"17","author":"X Chen","year":"2025","unstructured":"Chen X, Yang M, Huang Y, Tu J, Cai Y, Yuan X. Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy. Ther Adv Med Oncol. 2025;17:17588359251387534.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"16140_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijrobp.2021.04.009","volume":"111","author":"E Reijmen","year":"2021","unstructured":"Reijmen E, De Mey S, De Mey W, Gevaert T, De Ridder K, Locy H, et al. Fractionated radiation severely reduces the number of CD8+ T cells and mature antigen presenting cells within lung tumors. Int J Radiat Oncol Biol Phys. 2021;111(1):272\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"16140_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","volume":"12","author":"FG Herrera","year":"2022","unstructured":"Herrera FG, Ronet C, Ochoa de Olza M, Barras D, Crespo I, Andreatta M, et al. Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov. 2022;12(1):108\u201333.","journal-title":"Cancer Discov"},{"issue":"5","key":"16140_CR21","doi-asserted-by":"publisher","first-page":"e138740","DOI":"10.1172\/JCI138740","volume":"131","author":"C Lhuillier","year":"2021","unstructured":"Lhuillier C, Rudqvist NP, Yamazaki T, Zhang T, Charpentier M, Galluzzi L, et al. Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. J Clin Invest. 2021;131(5):e138740.","journal-title":"J Clin Invest"},{"issue":"1","key":"16140_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27(1):152\u201364.","journal-title":"Nat Med"},{"issue":"8","key":"16140_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2967\/jnumed.119.230714","volume":"61","author":"JJ Mueller","year":"2020","unstructured":"Mueller JJ, Dauer LT, Murali R, Iasonos A, Pandit-Taskar N, Abu-Rustum NR, et al. Positron lymphography via intracervical 18F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies. J Nucl Med. 2020;61(8):1123\u201330.","journal-title":"J Nucl Med"},{"issue":"2","key":"16140_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"16140_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2967\/jnumed.116.186353","volume":"58","author":"MA Lodge","year":"2017","unstructured":"Lodge MA. Repeatability of SUV in Oncologic 18F-FDG PET. J Nucl Med. 2017;58(4):523\u201332.","journal-title":"J Nucl Med"},{"key":"16140_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clinimag.2022.06.005","volume":"89","author":"CM Wilson","year":"2022","unstructured":"Wilson CM, Selwyn RG, Elojeimy S. Comparison of PET\/CT SUV metrics across different clinical software platforms. Clin Imaging. 2022;89:104\u201308.","journal-title":"Clin Imaging"},{"issue":"2","key":"16140_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2967\/jnmt.119.233353","volume":"48","author":"I Sarikaya","year":"2020","unstructured":"Sarikaya I, Albatineh AN, Sarikaya A. Revisiting weight-normalized SUV and lean-body-mass-normalized SUV in PET studies. J Nucl Med Technol. 2020;48(2):163\u201367.","journal-title":"J Nucl Med Technol"},{"issue":"4","key":"16140_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00259-023-06503-x","volume":"51","author":"CLC Smith","year":"2024","unstructured":"Smith CLC, Zwezerijnen GJC, den Hollander ME, Weijland J, Yaqub M, Boellaard R. Mitigating SUV uncertainties using total body PET imaging. Eur J Nucl Med Mol Imaging. 2024;51(4):1070\u201378.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16140-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:05:48Z","timestamp":1782774348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16140-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16140"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16140-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving animals were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of Anhui Medical University. The Animal Experimental Ethics Committee of Anhui Medical University approved the use of experimental mice in this study (Ethics Approval No.: LLSC20232073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"783"}}